Sun Pharma shares slip 3% after BofA downgrade on premium valuations

Sun Pharma shares slip 3% after BofA downgrade on premium valuations

Shares of Sun Pharmaceutical fell as much as 2.8% on Tuesday to an intraday low of Rs 1,610 on the BSE after Bank of America Securities downgraded the stock to ‘underperform’ from ‘neutral’, citing risks to premium valuations and slower-than-expected execution in speciality drugs. Bank of America Securities lowered its target price on Sun Pharma … Read more

Concurrent Gainers: Thermax, M&M among 8 stocks that gained for 5 days in a row

Concurrent Gainers: Thermax, M&M among 8 stocks that gained for 5 days in a row

Consistent Performers The week ended on February 23, and during this time, the Sensex benchmark index went up by about 1% compared to the previous five trading days, closing at 73143, showing a gain in three out of the last five sessions. During this up move, ETMarkets found eight stocks in the BSE500 index that … Read more